Supported by self-care line, Mustika Ratu sees a 53.82% surge in net profit
JAKARTA. PT Mustika Ratu Tbk (MRAT), a cosmetic company established in 1978, records a net profit growth of 53.82% year-on-year (yoy) in Q1 2021 to IDR 1.92 billion.
This profit growth coincides with the net sales performance reaching IDR 88.6 billion in Q1 2021. Compared to the number in Q1 2020, the company’s net sales grow by 30% yoy. This gain drives earning per share (EPS) of MRAT upward to IDR 4.48 per share in Q1 2021, climbing up from IDR 2.91 in Q1 2020.
According to idnfinancials.com data, the self-care business line is the largest contributor to MRAT sales in Q1 2021. This line brings in IDR 62.74 billion or 70.81% of the total sales. Then, health products sales add in IDR 21.4 billion, cosmetic products sales IDR 13.1 billion, and herbal medicine products sales IDR 9.57 billion.
As of March 31, 2021, PT Mustika Ratu Investama is still holding the control over 71.26% of MRAT’s shares. The remaining portion is dispersed among the public investors, each owning less than 5%. (KR/ZH)